// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored tec
This spring, long-time USP volunteer Dennis Gorecki, Ph.D., became the latest recipient of USP’s
Before COVID-19, most people might vaguely remember messenger RNA (mRNA) from a high school biolo